{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:35:58Z","timestamp":1785796558004,"version":"3.56.0"},"reference-count":27,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"unspecified","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Special Research Fund of Hasselt University","award":["BOF19PD04"],"award-info":[{"award-number":["BOF19PD04"]}]},{"name":"Fellowship of the Belgian American Educational Foundation"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL128526"],"award-info":[{"award-number":["HL128526"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2021,9,24]]},"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Mild aortic valve stenosis (AS) and aortic valve (AV) sclerosis are associated with diastolic dysfunction and increased mortality in the general population. This study specifically investigated the impact of mild AV disease in heart failure with preserved ejection fraction (HFpEF).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Consecutive patients hospitalised with HFpEF (n=370) underwent assessment of cardiac structure and function and long-term clinical follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the study cohort, 111 had mild AS (30%), 104 AV sclerosis (28%) and 155\u2009a non-calcified AV (42%). Mild-to-moderate AV regurgitation (AR) was present in 64 (17%). Compared with patients with a normal AV, those with AV disease were older, with worse renal function and more atrial fibrillation. E\/e\u2032 increased from non-calcified AV to AV sclerosis to mild AS (13.8 (10.8\u201316.8) vs 15.0 (10.9\u201320.0) vs 18.0 (12.7\u201323.3), respectively; p&lt;0.001)). Left ventricular diastolic pressure\u2013volume relationships were shifted leftwards in patients with AS and AV sclerosis, but not influenced by AR. The left ventricular end-diastolic volume normalised at 20\u2009mm Hg was 117\u00b134\u2009mL, 106\u00b130\u2009mL and 112\u00b130\u2009mL in non-calcified AV, AV sclerosis and mild AS, respectively (p=0.023), while 112\u00b132\u2009mL in mild-to-moderate AR. Over 30 months (IQR, 8\u201361 months), 247 patients died (67%). The presence of mild AV disease was associated with increased mortality, but this was no longer significant after adjusting for age and sex.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Low-grade AV disease is common among patients hospitalised for HFpEF and is associated with older age, atrial arrhythmia, renal dysfunction, higher left heart filling pressures and increased left ventricular chamber stiffness.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2021-001701","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T13:59:09Z","timestamp":1634738349000},"page":"e001701","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Mild aortic valve disease and the diastolic pressure\u2013volume relationship in heart failure with preserved ejection fraction"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0599-9290","authenticated-orcid":false,"given":"Frederik H","family":"Verbrugge","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA"},{"name":"Centre for Cardiovascular Diseases, University Hospital Brussels, Brussels, Belgium"},{"name":"Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh N V","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackram F","family":"Eleid","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Burkhoff","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Foundation, New York City, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9375-0596","authenticated-orcid":false,"given":"Barry A","family":"Borlaug","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"2025081710253393000_8.2.e001701.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(03)00201-X"},{"key":"2025081710253393000_8.2.e001701.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00563-3"},{"key":"2025081710253393000_8.2.e001701.3","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.11.1522"},{"key":"2025081710253393000_8.2.e001701.4","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000035655.45453.D2"},{"key":"2025081710253393000_8.2.e001701.5","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000255952.47980.c2"},{"key":"2025081710253393000_8.2.e001701.6","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2007.130971"},{"key":"2025081710253393000_8.2.e001701.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.08.036"},{"key":"2025081710253393000_8.2.e001701.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.03.019"},{"key":"2025081710253393000_8.2.e001701.9","doi-asserted-by":"publisher","DOI":"10.1161\/hc4101.097527"},{"key":"2025081710253393000_8.2.e001701.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.10.050"},{"key":"2025081710253393000_8.2.e001701.11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.026807"},{"key":"2025081710253393000_8.2.e001701.12","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/ejhf.1902","article-title":"Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease","volume":"22","author":"Packer","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2025081710253393000_8.2.e001701.13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.003071"},{"key":"2025081710253393000_8.2.e001701.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2017.01.007"},{"key":"2025081710253393000_8.2.e001701.15","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00455.2002"},{"key":"2025081710253393000_8.2.e001701.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)88335-0"},{"key":"2025081710253393000_8.2.e001701.17","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.15.1788"},{"key":"2025081710253393000_8.2.e001701.18","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01240.2005"},{"key":"2025081710253393000_8.2.e001701.19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.659763"},{"key":"2025081710253393000_8.2.e001701.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.09.063"},{"key":"2025081710253393000_8.2.e001701.21","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/CIRCULATIONAHA.119.042770","article-title":"Myocardial energetics in obesity: enhanced ATP delivery through creatine kinase with blunted stress response","volume":"141","author":"Rayner","year":"2020","journal-title":"Circulation"},{"key":"2025081710253393000_8.2.e001701.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.09.062"},{"key":"2025081710253393000_8.2.e001701.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.10.068"},{"key":"2025081710253393000_8.2.e001701.24","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/jc.2013-2963","article-title":"Plasma fibroblast growth factor 23, parathyroid hormone, 25-hydroxyvitamin D3, and risk of heart failure: a prospective, case-cohort study","volume":"99","author":"di Giuseppe","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2025081710253393000_8.2.e001701.25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.008959","article-title":"Determinants and impact of heart failure readmission following transcatheter aortic valve replacement","volume":"13","author":"Auffret","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2025081710253393000_8.2.e001701.26","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.echo.2018.07.001","article-title":"Exercise hemodynamics after aortic valve replacement for severe aortic stenosis","volume":"31","author":"Carter-Storch","year":"2018","journal-title":"J Am Soc Echocardiogr"},{"key":"2025081710253393000_8.2.e001701.27","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs299"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2021-001701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T17:25:42Z","timestamp":1755451542000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2021-001701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,10,20]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1136\/openhrt-2021-001701"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2021-001701","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}